Kwality Pharmaceuticals Ltd
Fri 14/08/2026,15:59:24 | NSE : KPL
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 3364.80
Previous Close
₹ 3343.00
Volume
41296
Mkt Cap ( ₹ Cr)
₹ 3565.78
High
₹ 3486.00
Low
₹ 3280.30
52 Week High
₹ 3486.00
52 Week Low
₹ 1561.00
Book Value Per Share
₹ 319.57
Dividend Yield
0.00
Face Value
₹ 10.00
What's Your Call?
Collective community sentiment on Kwality Pharmaceuticals Ltd
Your Vote -
Buy
75.00%
Hold
0.00%
Sell
25.00%
75.00%
8 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
0%
Sell Order Quantity
100%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
3436.50
597
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
597
Option Chain
Analyzes market sentiment, predicts Kwality Pharmaceuticals Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Kwality Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Kwality Pharma. - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Kwality Pharma. - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Kwality Pharma. - Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 U
-
Kwality Pharma. - Board Meeting Outcome for Submission Of Standalone And Consolidated Unaudited Financial Results For The Qua
-
Kwality Pharma. - Notice Convening The 43Rd Annual General Meeting (\AGM\) Of The Company On Monday, 31St August, 2026 At 12
-
Kwality Pharma. - Reg. 34 (1) Annual Report.
-
Kwality Pharma. - Intimation Of Book Closure
-
Kwality Pharma. - Intimation Of 43Rd Annual General Meeting
-
Kwality Pharma. - Board Meeting Outcome for Board Meeting Outcome For Intimation Of AGM
-
Kwality Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Kwality Pharma. - Board Meeting Intimation for Consideration And Approval Of Standalone & Consolidated Unaudited Financial Re
-
Kwality Pharma. - Disclosure Under Regulation 30 Of SEBI LODR
-
Kwality Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026
-
Kwality Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Kwality Pharma. - Announcement under Regulation 30 (LODR)-Resignation of Director
-
Kwality Pharma. - Announcement under Regulation 30 (LODR)-Change in Management
-
Kwality Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Kwality Pharma. - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Kwality Pharma. Q4 net profit jumps 74.41% at Rs 25.29 cr
-
Kwality Pharma. - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Kwality Pharma. - Audited Financial Results For The Quarter And Year Ended 31St March, 2026.
-
Kwality Pharma. - Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended 31St March, 2026
-
Kwality Pharmaceuticals
Key fundamentals
Evaluate the intrinsic value of Kwality Pharmaceuticals Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 463.833 | 378.2896 | 324.064 | 292.289 | 225.8491 |
| Liabilities | 463.833 | 378.2896 | 324.064 | 292.289 | 225.8491 |
| Equity | 10.3762 | 10.3762 | 10.3762 | 10.3762 | 10.3762 |
| Gross Profit | 118.2282 | 80.4432 | 66.6333 | 60.2887 | 171.7244 |
| Net Profit | 67.3466 | 39.8897 | 23.9839 | 19.4688 | 120.0466 |
| Cash From Operating Activities | 16.9999 | 52.7737 | 43.3473 | 42.1877 | 63.0607 |
| NPM(%) | 13.38 | 10.77 | 7.8 | 7.75 | 26.31 |
| Revenue | 503.0589 | 370.197 | 307.1718 | 250.9947 | 456.1316 |
| Expenses | 384.8307 | 289.7538 | 240.5385 | 190.706 | 284.4072 |
| ROE(%) | 20.3 | 12.02 | 7.23 | 5.87 | 36.2 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Kwality Pharmaceuticals Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 812.50 | 1.30 | 20.55 | 1965.99 | -26.19 | 0.62 |
| Lotus Eye Hospital and Institute Ltd | 115.22 | -1.19 | 1646.00 | 7163.81 | 0.39 | 0.00 |
| Vaishali Pharma Ltd | 8.51 | 0.47 | 26.59 | 44940.93 | 15.42 | 0.00 |
| Astec Lifesciences Ltd | 593.95 | -1.35 | 0.00 | 7675.63 | -363.14 | 0.00 |
Company Info
The Company was originally incorporated as Kwality Pharmaceuticals Private Limited on May 04, 1983 with the Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh. Further the name of the Company was changed to Kwality Pharmaceuticals Limited vide a fresh certificate of incorporation dated December 28, 2015 issued by the Registrar of Companies, Chandigarh. The Corporate Identification Number is U24232PB1983PLC005426. The Promoters of the Company are Mr. Ramesh Arora and Mr. Ajay Arora. The Company is primarily engaged in the business of manufacturing of broad range of finished pharmaceutical formulations in a dosage form. The Company does not have RoC filings with respect to Form 2 made in the period prior to 2003, in order to ascertain allotments made during the period from May 04, 1983, till March 29, 2003. However, the Company has maintained Register of Members since inception and we have relied on the limited information available in the Minute Book and Register of Members of the Company. The relevant documents are also not available/destroyed at the office of the RoC Chandigarh as certified by Rishi Mittal & Associates, Company Secretaries, dated May 30, 2016. Therefore, the Company is unable to provide any disclosures or make any confirmations on all of the aforementioned matters. The disclosures pertaining to the aforementioned matters currently made in this Prospectus are subject to information readily available from public domains and other limited records. The Registered Office of the Company is situated at Village Nagkalan, Majitha Road, Amritsar - 143601. Major Events and Milestones : 1983 -Incorporation of the Company on May 04, 1983 2007 -Received ISO Certification 2008 -Commencement of new manufacturing unit at Jassur in Himachal Pradesh 2009 -Received status of Star Export House Certificate 2012 -Turnover increased by 75% 2013 -Incorporation of Subsidiary Company in Africa 2014 -Received WHO certification 2016 -Kwality Pharmaceuticals are listed and admitted to dealings on the Exchange in the list of 'MT' Group Securities. 2017 The Company has allotted on October 13, 2017, 51,88,099 Equity Shares of Rs. 10/- each, as Bonus Shares in the ratio of 1:1 to the shareholders whose names appear on the Register of Members/Depositories as on record date i.e. October 12, 2017. 2024 -The Company Received Its First Biological Product Permission For Manufacturing And Sale Of Pegylated-Aspa. -Business Icon Award-Presented by AIPL DreamCity - 2024 2025 -Kwality Pharma receives product registration for Bleomycin 15 IU In Mexico for sale and distribution -Kwality Pharmaceuticals Limited receives product registrartion of Cyclophosphamide 1gm in Mexico
The Company was originally incorporated as Kwality Pharmaceuticals Private Limited on May 04, 1983 with the Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh. Further the name of the Company was changed to Kwality Pharmaceuticals Limited vide a fresh certificate of incorporation dated December 28, 2015 issued by the Registrar of Companies, Chandigarh. The Corporate Identification Number is U24232PB1983PLC005426. The Promoters of the Company are Mr. Ramesh Arora and Mr. Ajay Arora. The Company is primarily engaged in the business of manufacturing of broad range of finished pharmaceutical formulations in a dosage form. The Company does not have RoC filings with respect to Form 2 made in the period prior to 2003, in order to ascertain allotments made during the period from May 04, 1983, till March 29, 2003. However, the Company has maintained Register of Members since inception and we have relied on the limited information available in the Minute Book and Register of Members of the Company. The relevant documents are also not available/destroyed at the office of the RoC Chandigarh as certified by Rishi Mittal & Associates, Company Secretaries, dated May 30, 2016. Therefore, the Company is unable to provide any disclosures or make any confirmations on all of the aforementioned matters. The disclosures pertaining to the aforementioned matters currently made in this Prospectus are subject to information readily available from public domains and other limited records. The Registered Office of the Company is situated at Village Nagkalan, Majitha Road, Amritsar - 143601. Major Events and Milestones : 1983 -Incorporation of the Company on May 04, 1983 2007 -Received ISO Certification 2008 -Commencement of new manufacturing unit at Jassur in Himachal Pradesh 2009 -Received status of Star Export House Certificate 2012 -Turnover increased by 75% 2013 -Incorporation of Subsidiary Company in Africa 2014 -Received WHO certification 2016 -Kwality Pharmaceuticals are listed and admitted to dealings on the Exchange in the list of 'MT' Group Securities. 2017 The Company has allotted on October 13, 2017, 51,88,099 Equity Shares of Rs. 10/- each, as Bonus Shares in the ratio of 1:1 to the shareholders whose names appear on the Register of Members/Depositories as on record date i.e. October 12, 2017. 2024 -The Company Received Its First Biological Product Permission For Manufacturing And Sale Of Pegylated-Aspa. -Business Icon Award-Presented by AIPL DreamCity - 2024 2025 -Kwality Pharma receives product registration for Bleomycin 15 IU In Mexico for sale and distribution -Kwality Pharmaceuticals Limited receives product registrartion of Cyclophosphamide 1gm in Mexico
Read More
Parent Organisation
Kwality Pharmaceuticals Ltd.
Founded
04/05/1983
Managing Director
Mr.Ramesh Kumar
NSE Symbol
KPLEQ
FAQ
The current price of Kwality Pharmaceuticals Ltd is ₹ 3436.50.
The 52-week high for Kwality Pharmaceuticals Ltd is ₹ 3486.00 and the 52-week low is ₹ 3280.30.
The market capitalization of Kwality Pharmaceuticals Ltd is currently ₹ 3565.78. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Kwality Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Kwality Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Kwality Pharmaceuticals Ltd shares.
The CEO of Kwality Pharmaceuticals Ltd is Mr.Ramesh Kumar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
